30 MARCH 2022

PHARMANIAGA PARTNERS UAE’S PRIME HEALTHCARE GROUP TO MARKET PHARMACEUTICAL PRODUCTS IN UAE AND OTHER GULF COUNTRIES

3 MARCH 2022

MALAYSIA APPROVES SINOVAC COVID-19 VACCINE FOR CHILDREN AGED 5 TO 11 YEARS

25 FEBRUARY 2022

PHARMANIAGA SIGNS MOU WITH TECHNICAL PARTNERS IN THAILAND TO STRENGTHEN GROWTH

21 FEBRUARY 2022

PHARMANIAGA CONTINUES TO CAPTURE INTERNATIONAL EXPANSION OPPORTUNITIES

17 FEBRUARY 2022

PHARMANIAGA GEARS UP IN DELIVERING BUSINESS STRATEGIES GROWTH

9 FEBRUARY 2022

PRESEARCH SHOWS TWO DOSES OF SINOVAC COVID-19 WITH PFIZER BOOSTER LESS EFFECTIVE TO FIGHT AGAINST OMICRON VARIANT

27 JANUARY 2022

PHARMANIAGA ANNOUNCES TOP LEADERSHIP CHANGES AS IT MOVES FORWARD TO BECOME A REGIONAL PHARMACEUTICAL KEY PLAYER

22 JANUARY 2022

最新研究表明，在 95% 的奥密克戎变种接受者中，使用三剂科兴新冠病毒疫苗可以中和抗体

22 JANUARY 2022

KAJIAN TERKINI MENUNJUKKAN TIGA DOS VAKSIN COVID-19 SINOVAC NEUTRALKAN 95% ANTIBODI INDIVIDU MELAWAN VARIAN OMICRON

22 JANUARY 2022

SINOVAC BIOTECH DATA SHOWS THREE DOSES OF SINOVAC COVID-19 VACCINE EFFECTIVE TO FIGHT AGAINST OMICRON VARIANT

11 JANUARY 2022

PHARMANIAGA RECEIVES CONDITIONAL LETTER FOR CONTINUATION OF MEDICAL SUPPLY LOGISTICS TO MINISTRY OF HEALTH FOR 10 YEARS

1 JANUARY 2022

KEPUTUSAN AWAL KAJIAN UNIVERSITI KATOLIK DI CHILE MENUNJUKKAN DOS PENGGALAK VAKSIN COVID-19 SINOVAC AKTIFKAN IMUNITI SELULAR TERHADAP VARIAN OMICRON

1 JANUARY 2022

PRELIMINARY RESULTS FROM THE CATHOLIC UNIVERSITY IN CHILE SHOWS BOOSTER DOSE OF SINOVAC COVID-19 VACCINE ACTIVATE CELLULAR IMMUNITY AGAINST OMICRON VARIANT

1 JANUARY 2022

PRELIMINARY RESULTS FROM THE CATHOLIC UNIVERSITY IN CHILE SHOWS BOOSTER DOSE OF SINOVAC COVID-19 VACCINE ACTIVATE CELLULAR IMMUNITY AGAINST OMICRON VARIANT (MANDARIN VERSION)

30 DECEMBER 2021

PHARMANIAGA PROVIDES EMERGENCY AID, MEDICAL SUPPLIES AND VOLUNTEERS TO FLOOD VICTIMS IN SELANGOR, NEGERI SEMBILAN AND PAHANG

20 DECEMBER 2021

PHARMANIAGA’S DELIVERIES OF MEDICINES NATIONWIDE UNAFFECTED BY FLOOD AND WILL CONTINUE AS USUAL

18 DECEMBER 2021

SINOVAC BOOSTER SHOTS EARLY DATA SHOWS 94% EFFECTIVE AGAINST OMICRON

2 DECEMBER 2021

PHARMANIAGA DELIVERS SINOVAC COVID-19 VACCINE ON THE 1ST OF AUGUST 2021, AHEAD OF TIME AS REQUESTED BY THE GOVERNMENT TO ACCELERATE NATIONAL COVID-19 IMMUNISATION PROGRAMMERE SECTORS

1 DECEMBER 2021

PHARMANIAGA DELIVERS STRONG FINANCIAL PERFORMANCE, SUPPORTS GOVERNMENT TO SERVE RAKYAT ACROSS VARIOUS HEALTHCARE SECTORS

30 NOVEMBER 2021

SINOVAC, GLOBAL PARTNERS TURN FOCUS TO FIGHT AGAINST OMICRON COVID-19 VARIANT

22 NOVEMBER 2021

PHARMANIAGA SUMBANG RM3.5 JUTA KEPADA LEMBAGA ZAKAT SELANGOR

19 NOVEMBER 2021

PHARMANIAGA GIVES BACK TO KELUARGA MALAYSIA WHILST CONTINUING THE FIGHT AGAINST COVID-19

18 NOVEMBER 2021

MALAYSIA APPROVES SINOVAC COVID-19 VACCINE BOOSTER SHOT FOR 18 YEARS AND ABOVE AVAILABLE FOR PRIVATE MARKET

15 NOVEMBER 2021

PHARMANIAGA TEMBUSI PASARAN VAKSIN ANTARABANGSA EKSPORT VAKSIN SINOVAC COVID-19 KE MYANMAR